Cerenome (CNSY)
Diagnostic testing and targeted radiotherapy development for central nervous system cancers.
$1.95
vs last close−0.08 (−3.94%)
Something off on this page? Send us feedback.
Next report
Oct 15, 26
estimated · in 22 days
EPS estimate
−$0.92
Revenue estimate
$1.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Oct '25Mar '26May '26Aug '26Oct '26
Reported−$9.50−$29.75$0.50−$1.00−$0.83−$1.05−$1.31Pending
Estimate−$12.42−$6.20−$2.25−$0.50−$0.80−$0.85−$0.88−$0.92
Surprise+23.5%−379.7%+122.2%−100.0%−4.2%−23.8%−48.9%—
RevenueReportedEstimate
Mar '25May '25Aug '25Oct '25Mar '26May '26Aug '26Oct '26
Reported$1.4M$1.1M$1.4M$1.4M$1.4M$1.0M$411.0KPending
Estimate$1.5M$1.5M$1.5M$1.5M$1.2M$974.0K$1.1M$1.3M
Surprise−6.4%−28.6%−6.5%−6.5%+10.6%+5.5%−63.1%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.64 | — | — |
| Sep 2028 | −$0.89 | — | — |
| Jun 2028 | −$0.86 | — | — |
| Mar 2028 | −$1.04 | — | — |
| Dec 2027 | −$0.66 | — | — |
| Sep 2027 | −$0.65 | — | — |
| Jun 2027 | −$0.78 | — | — |
| Mar 2027 | −$0.78 | — | — |
| Dec 2026 | −$0.67 | — | — |
| Oct 2026 | −$0.92 | — | — |
| Aug 2026 | −$0.88 | −$1.31 | −48.9% |
| May 2026 | −$0.85 | −$1.05 | −23.8% |
| Mar 2026 | −$0.80 | −$0.83 | −4.2% |
| Oct 2025 | −$0.50 | −$1.00 | −100.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Jul 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| May 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.64 | — | — | $10.8M | — | — | — |
| Sep 2028 | −$0.89 | — | — | $10.4M | — | — | — |
| Jun 2028 | −$0.86 | — | — | $9.6M | — | — | — |
| Mar 2028 | −$1.04 | — | — | $9.2M | — | — | — |
| Dec 2027 | −$0.66 | — | — | $3.0M | — | — | — |
| Sep 2027 | −$0.65 | — | — | $3.0M | — | — | — |
| Jun 2027 | −$0.78 | — | — | $2.0M | — | — | — |
| Mar 2027 | −$0.78 | — | — | $2.0M | — | — | — |
| Dec 2026 | −$0.67 | — | — | $3.6M | — | — | — |
| Oct 15, 2026 | −$0.92 | — | — | $1.3M | — | — | — |
| Aug 14, 2026 | −$0.88 | −$1.31 | −48.9% | $1.1M | $411.0K | −63.1% | −13.0% |
| May 15, 2026 | −$0.85 | −$1.05 | −23.8% | $974.0K | $1.0M | +5.5% | — |
| Mar 12, 2026 | −$0.80 | −$0.83 | −4.2% | $1.2M | $1.4M | +10.6% | — |
| Oct 30, 2025 | −$0.50 | −$1.00 | −100.0% | $1.5M | $1.4M | −6.5% | — |
| Aug 14, 2025 | |||||||
| May 30, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 5, 2024 | |||||||
| Oct 31, 2023 | |||||||
| Aug 14, 2023 | |||||||
| Apr 20, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Oct 20, 2022 | |||||||
| Jul 21, 2022 | |||||||
| Apr 21, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Oct 21, 2021 | |||||||
| Jul 22, 2021 | |||||||
| Jul 6, 2021 | |||||||
| Feb 22, 2021 | |||||||
| Oct 22, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 30, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 15, 2019 | |||||||
| May 14, 2019 | |||||||
| Mar 29, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Aug 14, 2018 | |||||||
| May 11, 2018 | |||||||
| Mar 9, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 11, 2017 | |||||||
| May 12, 2017 | |||||||
| Mar 24, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 5, 2016 | |||||||
| May 10, 2016 | |||||||
| Nov 6, 2015 | |||||||
| Aug 10, 2015 | |||||||
| May 11, 2015 |